Abstract

Assignment to treatment group by randomization has been advocated with great success in biomedical trials. Research on optimal experimental design suggests, however, that it should be possible to obtain efficiency gains over randomization by balancing treatment groups with regard to prognostic factors. The only practical way of doing this involves sequential allocation to treatment that evolves during the recruitment period, but any such method has been questioned on the grounds that statistical inference using the estimated treatment effect is suspect. Results reported here show by means of a regression simulation that the estimate obtained from a dynamically balanced trial is unbiased, and a new estimate of its standard deviation is similarly shown to be unbiased. If one does not adjust for the balancing factors in the analysis, then randomization is frequently unacceptably inefficient. If one does adjust, then the efficiency advantage of balancing is modest on average, but still important in an appreciable fraction of trials with small sample sizes.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.